KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Amortizatization of Intangibles (2016 - 2025)

Ionis Pharmaceuticals (IONS) has 13 years of Amortizatization of Intangibles data on record, last reported at $8.4 million in Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles rose 3.47% year-over-year to $8.4 million; the TTM value through Dec 2025 reached $10.2 million, up 2.06%, while the annual FY2025 figure was $10.2 million, 2.06% up from the prior year.
  • Amortizatization of Intangibles reached $8.4 million in Q4 2025 per IONS's latest filing, up from -$11.2 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $11.9 million in Q2 2023 and bottomed at -$11.2 million in Q3 2025.
  • Average Amortizatization of Intangibles over 5 years is $1.5 million, with a median of $625500.0 recorded in 2021.
  • The widest YoY moves for Amortizatization of Intangibles: up 1314.73% in 2022, down 1159.64% in 2022.
  • A 5-year view of Amortizatization of Intangibles shows it stood at $612000.0 in 2021, then skyrocketed by 481.21% to $3.6 million in 2022, then tumbled by 231.43% to -$4.7 million in 2023, then skyrocketed by 274.61% to $8.2 million in 2024, then increased by 3.47% to $8.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Amortizatization of Intangibles were $8.4 million in Q4 2025, -$11.2 million in Q3 2025, and $5.9 million in Q2 2025.